Humana reports grim forecast for 2024 due to rising medical costs
Signs are displayed at a Humana Inc. office building in Louisville, Kentucky, U.S., Sunday, February 3, 2019. Humana is scheduled…
Biotechnology
Johnson & Johnson to resolve baby powder investigation
Containers of Johnson and Johnson baby powder are displayed on a shelf at Walgreens on April 5, 2023 in San…
Johnson & Johnson (JNJ) Q4 2023 Earnings
Johnson & Johnson stock chart seen on a smartphone screen. Rafael Enrique | SOPA Images | Light rocket | fake…
These four stocks of anti-obesity drugs could skyrocket, says Berenberg
The anti-obesity drug market is expected to remain in the spotlight this year after a bumper 2023 for weight loss…
Gilead Shares Fall After Disappointing Lung Cancer Study Results
soup images | Light rocket | fake images Actions of Gilead fell more than 9% on Monday after a key…
Boehringer Ingelheim, Terns and Viking could join the market
Still life of Wegovy, an injectable prescription weight loss medication that has helped people with obesity. It should be used…
Citi and others are bullish on biotech, medtech and more
2023 was not a good year for the healthcare sector, but some investors expect it to return this year, highlighting…
Renewed interest in ADCs will continue in 2024
Medical personnel use a mammogram to examine a woman's breast for breast cancer. Hannibal Hanschke | dpa | Image Alliance…
CVS to close 'select' pharmacies in Target stores in coming months
CVS Health plans to close selected pharmacies within Aim stores earlier this year, a company spokesperson said Thursday, as retail…
J&J to acquire Ambrx Biopharma, a cancer drug developer, for $2 billion
An entrance sign to the Johnson & Johnson campus displays its logo in Irvine, California, on August 28, 2019. Marcos…